Giant cell tumor of tendon sheath pathology outlines

Review

Tenosynovial giant cell tumor: case report and review

David R Lucas. Arch Pathol Lab Med. 2012 Aug.

Free article

Abstract

Tenosynovial giant cell tumors are a group of generally benign intra-articular and soft tissue tumors with common histologic features. They can be roughly divided into localized and diffuse types. Localized types include giant cell tumors of tendon sheath and localized pigmented villonodular synovitis, whereas diffuse types encompass conventional pigmented villonodular synovitis and diffuse-type giant cell tumor. Localized tumors are generally indolent, whereas diffuse tumors are locally aggressive. Recent developments indicate that tenosynovial giant cell tumors are clonal neoplastic tumors driven by overexpression of CSF1. Herein, I report a case of intra-articular, localized tenosynovial giant cell tumor (or localized pigmented villonodular synovitis) and review the classification, histopathology, and recent developments regarding its pathogenesis.

Similar articles

  • Pigmented villonodular bursitis/diffuse giant cell tumor of the pes anserine bursa: a report of two cases and review of literature.

    Maheshwari AV, Muro-Cacho CA, Pitcher JD Jr. Maheshwari AV, et al. Knee. 2007 Oct;14(5):402-7. doi: 10.1016/j.knee.2007.06.004. Epub 2007 Jul 31. Knee. 2007. PMID: 17669658 Review.

  • Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.

    Kim DE, Kim JM, Lee BS, Kim NK, Lee SH, Bin SI. Kim DE, et al. Knee Surg Sports Traumatol Arthrosc. 2018 Nov;26(11):3508-3514. doi: 10.1007/s00167-018-4942-2. Epub 2018 Apr 10. Knee Surg Sports Traumatol Arthrosc. 2018. PMID: 29637236

  • Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis.

    Fiocco U, Sfriso P, Lunardi F, Pagnin E, Oliviero F, Scagliori E, Cozzi L, Vezzù M, Molena B, Scanu A, Panziera C, Nardacchione R, Rubaltelli L, Dayer JM, Calabrese F, Punzi L. Fiocco U, et al. Autoimmun Rev. 2010 Sep;9(11):780-4. doi: 10.1016/j.autrev.2010.07.001. Epub 2010 Jul 8. Autoimmun Rev. 2010. PMID: 20620241 Review.

  • Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis: defining the presentation, surgical therapy and recurrence.

    Martin RC 2nd, Osborne DL, Edwards MJ, Wrightson W, McMasters KM. Martin RC 2nd, et al. Oncol Rep. 2000 Mar-Apr;7(2):413-9. Oncol Rep. 2000. PMID: 10671695 Review.

  • A tenosynovial giant cell tumor arising from femoral attachment of the anterior cruciate ligament.

    Lee JH, Wang SI. Lee JH, et al. Clin Orthop Surg. 2014 Jun;6(2):242-4. doi: 10.4055/cios.2014.6.2.242. Epub 2014 May 16. Clin Orthop Surg. 2014. PMID: 24900909 Free PMC article.

Cited by

  • PD-L1 Status in Tenosynovial Giant Cell Tumors.

    Zenginkinet T, Faruq AU, Toksoz Yildirim AN, Iyetin Y, Ozturan B, Okay E, Celik A, Ozkan K, Akyurek M. Zenginkinet T, et al. Medicina (Kaunas). 2022 Sep 13;58(9):1270. doi: 10.3390/medicina58091270. Medicina (Kaunas). 2022. PMID: 36143947 Free PMC article.

  • Extra-articular tenosynovial chondromatosis of the right fifth digit in a 59-year-old man: A case report and literature review.

    Qi-Huang S, Jacho FAL, David L, Weingarten E. Qi-Huang S, et al. J Radiol Case Rep. 2021 Aug 1;15(8):8-17. doi: 10.3941/jrcr.v15i8.4212. eCollection 2021 Aug. J Radiol Case Rep. 2021. PMID: 35586796 Free PMC article. Review.

  • A New Simple and Practical Clinical Classification for Tenosynovial Giant Cell Tumors of the Knee.

    Zheng K, Yu XC, Hu YC, Xu M, Zhang JY. Zheng K, et al. Orthop Surg. 2022 Feb;14(2):290-297. doi: 10.1111/os.13179. Epub 2021 Dec 16. Orthop Surg. 2022. PMID: 34914180 Free PMC article.

  • Giant Cell Tumor of Tendon Sheath in Knee Capsule.

    Alghamdi B, Koaban S, Alnaqa H. Alghamdi B, et al. Cureus. 2021 Jul 26;13(7):e16632. doi: 10.7759/cureus.16632. eCollection 2021 Jul. Cureus. 2021. PMID: 34336534 Free PMC article.

  • Arthroscopic Removal of Tenosynovial Giant-Cell Tumors of the Cruciate Ligaments. Presentation of Two Cases.

    Flevas DA, Karagiannis AA, Patsea ED, Kontogeorgakos VA, Chouliaras VT. Flevas DA, et al. J Orthop Case Rep. 2021 Apr;11(4):23-27. doi: 10.13107/jocr.2021.v11.i04.2136. J Orthop Case Rep. 2021. PMID: 34327159 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

  • Full Text Sources

    • Silverchair Information Systems
  • Research Materials

    • NCI CPTC Antibody Characterization Program
  • Miscellaneous

    • NCI CPTAC Assay Portal

What is giant cell tumor of tendon sheath?

Giant cell tumor of tendon sheath (GCTTS) is clinically a slow growing soft tissue mass that develops over a period of months to years. It is the second commonest tumor of the hand [1]. Trauma, inflammation, metabolic disease and a neoplastic etiology are considered as etiological factors [2, 3].

How do you get rid of a giant cell tumor of the tendon sheath?

Surgery is the main treatment for tenosynovial giant cell tumors. Your doctor may remove some or all of the tumors, as well as the inflamed joint tissue. You may need another surgery if the tumor returns. ‌The tumors can be removed by open surgery or arthroscopic surgery, which is a less invasive procedure.

Is giant cell tumor malignant or benign?

Most giant cell tumors occur at the ends of the long bones of the arms and legs, near a joint (such as the knee, wrist, hip, or shoulder). Most are benign (not cancer) but some are malignant (cancer). Giant cell tumors usually occur in young and middle-aged adults. Also called GCT.

What is the most common site for giant cell tumors?

A giant cell tumor is a rare, aggressive non-cancerous tumor. It usually develops near a joint at the end of the bone. Most occur in the long bones of the legs and arms. Giant cell tumors most often occur in young adults when skeletal bone growth is complete.